Your browser doesn't support javascript.
loading
CD36 defines primitive chronic myeloid leukemia cells less responsive to imatinib but vulnerable to antibody-based therapeutic targeting.
Landberg, Niklas; von Palffy, Sofia; Askmyr, Maria; Lilljebjörn, Henrik; Sandén, Carl; Rissler, Marianne; Mustjoki, Satu; Hjorth-Hansen, Henrik; Richter, Johan; Ågerstam, Helena; Järås, Marcus; Fioretos, Thoas.
Afiliación
  • Landberg N; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden niklas.landberg@med.lu.se thoas.fioretos@med.lu.se.
  • von Palffy S; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Askmyr M; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Lilljebjörn H; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Sandén C; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Rissler M; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Mustjoki S; Hematology Research Unit Helsinki, Department of Clinical Chemistry and Hematology, University of Helsinki, and Helsinki University Hospital Comprehensive Cancer Center, Finland.
  • Hjorth-Hansen H; Department of Hematology, St Olavs Hospital, Trondheim, Norway.
  • Richter J; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
  • Ågerstam H; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Järås M; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden.
  • Fioretos T; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Sweden niklas.landberg@med.lu.se thoas.fioretos@med.lu.se.
Haematologica ; 103(3): 447-455, 2018 03.
Article en En | MEDLINE | ID: mdl-29284680
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Antígenos CD36 / Mesilato de Imatinib / Citotoxicidad Celular Dependiente de Anticuerpos Límite: Humans Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Mieloide de Fase Crónica / Antígenos CD36 / Mesilato de Imatinib / Citotoxicidad Celular Dependiente de Anticuerpos Límite: Humans Idioma: En Revista: Haematologica Año: 2018 Tipo del documento: Article